您的当前位置:首页 > 行业数据 > Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较
图片属性
图片格式:PNG 图片大小:822KB 图片尺寸:2302*1029
同报告图片
 / 4
Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较_第1页
fCBBICAgICAgIHwgVG90YWwgU2VxdWVuY2UgfCBVbmlxdWUgU2VxdWVuY2UgfAp8LS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS18CnwgSHlicmlkb21hIHwgMzAgICAgICAgICAgICAgfCAxMyAgICAgICAgICAgICAgfAp8IEJlYWNvbiAgIHwgNzUgICAgICAgICAgICAgfCA0NCAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45YWs5LyX5Y+377yM5Lit5rOw6K+B5Yi456CU56m25omA
Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较_第2页
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
Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较_第3页
fCBWSCB8IEQgfCBKIHwgQ0ggfCBMQ1IgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgIHwgIHwgIHwgIHwgIHwKfCAgfCAgfCAgfCAgfCAgfAp8ICB8ICB8ICB8ICB8ICB8
Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较_第4页
Beacon®单B细胞技术平台与杂交瘤技术产生的抗体比较_第5页
所属报告: 和铂医药~B-港股公司深度报告:依托稀缺Harbour Mice平台BD之王开启新篇章-250620(27页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠